Skip to main contentSkip to navigation
Sirius Investors

TTRX Stock: Turn Therapeutics Inc. Stock Price, Analysis & Insights

Get live ttrx stock price $6.51, comprehensive Turn Therapeutics Inc. stock analysis, charts, news, and expert forecast. Real-time ttrx stock data and investment insights.

6.51
12.62%Today
TTRXTurn Therapeutics Inc. • NASDAQ Global Select • Healthcare
Market Cap
182.43M
Volume
441.51K
52W High
26.50
52W Low
6.08
Upgrade to Pro or Premium to access long-term historical data (3M, 6M, 1Y, 2Y, 5Y, 10Y, Max)

Company Overview

Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.

Company Information

CEO
Bradley E. Burnam
Sector
Healthcare
Industry
Biotechnology
Employees
2

Contact Information

Address
250 N Westlake Blvd
Country
US

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 182.43M market capitalization
  • Trading Volume: 441.51K shares traded today
  • Price Range: 52-week range of $6.08 - $26.50
  • Exchange: Listed on NASDAQ Global Select

Financial Metrics

P/E Ratio:-72.33
EPS:$-0.09
Beta:0.00
Avg Volume:6.97M

Market Analysis for Turn Therapeutics Inc.

Turn Therapeutics Inc. (TTRX) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 182.43M, the company represents a significant player in its market. The stock is currently trading at $6.51 with a negativedaily change of 12.62%.

The company's 2 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -72.33, beta of 0.00, and 52-week price range from $6.08 to $26.50when evaluating investment opportunities.

Why Invest in Turn Therapeutics Inc.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Global Select)
  • • Experienced leadership under Bradley E. Burnam
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.